Valomaciclovir stearate (Synonyms: Valomaciclovir stearate; A-174606.0; A 174606.0; A174606.0; ABT-606; ABT 606; ABT606; EPB-348; EPB348; EPB 348; MIV-606; MIV 606; MIV606; RP-606; RP606; RP 606;) |
| Catalog No.GB62264 |
Valomaciclovir stearate (A-174606.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 195156-77-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Valomaciclovir stearate (A-174606.0; ABT-606; EPB-348; MIV-606; RP-606) is a DNA polymerase inhibitor potentially for treatment of acute herpes zoster and EB virus infection. Valomaciclovir stearate is an orally available and a prodrug of Valomaciclovir with broad-spectrum antiviral activity against a variety of important herpesviruses, including Epstein-Barr virus, or EBV (the first virus to be directly associated with human cancer), varicella zoster virus, or herpes zoster (cause of shingles), and herpes simplex virus 1 and 2.
Review for Valomaciclovir stearate
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Valomaciclovir stearate
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *